Physician profile
Bryan Ni
NPI 1922410281
$555.97
in general payments reported to CMS, 2019-2025
13 companies · $173 in 2025
The $173 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.15 · 2020: $24.20 · 2021: $34.42 · 2022: $76.53 · 2023: $134 · 2024: $14.62 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $119.59 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.69 | 2023-2025 | Xifaxan |
| Pacira Pharmaceuticals Incorporated | $65.06 | 2021-2023 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $62.01 | 2023-2025 | Entyvio |
| Merck Sharp & Dohme LLC | $48.60 | 2021-2025 | Bridion |
| Janssen Biotech, INC. | $47.47 | 2025 | Tremfya |
| Baxter Healthcare | $24.20 | 2020 | |
| Vyaire Medical, INC. | $22.17 | 2022 | |
| Mallinckrodt Enterprises LLC | $21.02 | 2019 | |
| Intercept Pharmaceuticals, INC. | $19.14 | 2025 | |
| Ucb, INC. | $19.06 | 2019 | |
| Heron Therapeutics, INC. | $18.98 | 2023 | Aponvie |
| Shionogi INC | $16.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Ni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.